# CshMedi

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cshmedi

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Total disclosed funding: $14M
- Latest round: Series A (Aug 28, 2023)
- Investors on record: 4

## About

Based in Shanghai, China and established in 2009, CshMedi is a biomedical magnetic medical imaging equipment developer, engaged in the research of biomagnetic medical instrument. The company has cooperated with CAS Shanghai Microsystems to develop cardiac magnetic medical examination equipment since 2006. It has become the first manufacturer approved by the National Medical Products Administration (NMPA) and China Food And Drug Administration (CFDA) in China. In 2019, CshMedi obtained Shanghai CFDA medical device registration certificate and production license. In August 2023, it raised approximately CNY 100 million in series A funding.


CshMedi offers cardiac magnetic medical examination equipment, which is a functional science examination device that acquires and analyzes the magnetic field signals of the human heart. The company uses a superconducting quantum interference device (SQUID) as the core magnetic detector. This helps address some of the shortcomings of cardiovascular magnetic resonance imaging (CMR). The device can be used in cardiology departments, cardiac rehabilitation centers, and medical imaging centers to diagnose the location of cardiac diseases, including myocardial ischemia and arrhythmias.

The company plans to conduct large-scale clinical studies of MCG as well as enrollment in clinical trials of a fetal magnetocardiograph (fMCG) for early congenital heart disease screening.

## Funding rounds

- Series A, Aug 28, 2023, $14M — Xin Ding Capital
- Series A, Sep 10, 2021 — CASH Capital, Shanghai Guoxin Venture Capital Investment
- Angel, Apr 8, 2018 — New Alliance Capital

## Investors

- New Alliance Capital (https://capitalatlas.ai/funds/new-alliance-capital) — Angel
- CASH Capital (https://capitalatlas.ai/funds/cash-capital) — Series A
- Shanghai Guoxin Venture Capital Investment — Series A
- Xin Ding Capital (https://capitalatlas.ai/funds/xin-ding-capital) — Series A
